Performance evaluation of Xpert HBV viral load (VL) assay: Point-of-care molecular test to strengthen and decentralize management of chronic hepatitis B (CHB) infection
- PMID: 33453301
- DOI: 10.1016/j.jviromet.2021.114063
Performance evaluation of Xpert HBV viral load (VL) assay: Point-of-care molecular test to strengthen and decentralize management of chronic hepatitis B (CHB) infection
Abstract
Introduction: Estimation of hepatitis B (HBV) viral load (VL) is critical in hepatitis-B cascade-of-care and at present there is no point of care (POC) molecular assay available for the same. This study evaluated the performance of a new near point of care molecular assay Xpert HBV- VL assay against the approved assays.
Materials & methods: In this study 172 archived previously tested samples, were simultaneously re-tested for HBV DNA on 3 real-time PCR assays: Abbott Real-Time HBV, Roche TaqMan® HBV and Xpert HBV assay.
Results: Out of 172 samples, 119 were previously positive for HBV DNA with a median VL 4.46 (IQR: 1-8.76)log10IU/mL and 53 were HBV DNA negative. Genotyping could be done in 95 (79.8 %) samples and genotype D (83; 87.3 %) was the commonest type. The Xpert assay demonstrated a good correlation with Abbott (R2 = 0.94) and Roche (R2 = 0.96). On comparison, the mean difference with 95 % Confidence Interval of Xpert assay was -0.018 and -0.043 log10 IU/mL with Abbott and Roche assay, respectively. The overall sensitivity, specificity, negative predictive value, and positive predictive value of the Xpert assay was found 97.5 %, 100 %, 94.65 & 100 % respectively.
Conclusion: Xpert HBV-VL assay which has a potential for near point of care molecular testing has shown excellent performance and found to be a reliable method for HBV DNA quantification.
Keywords: Chronic hepatitis B; Gene Xpert; HBV DNA; HBV genotype; HBsAg; Real time PCR; Viral load.
Copyright © 2021. Published by Elsevier B.V.
Similar articles
-
Rapid, random-access, and quantification of hepatitis B virus using the Cepheid Xpert HBV viral load assay.J Med Virol. 2021 Jun;93(6):3999-4003. doi: 10.1002/jmv.26392. Epub 2020 Aug 25. J Med Virol. 2021. PMID: 32761911 Free PMC article.
-
Validity of a point-of-care viral load test for hepatitis B in a low-income setting.J Virol Methods. 2021 Mar;289:114057. doi: 10.1016/j.jviromet.2020.114057. Epub 2020 Dec 29. J Virol Methods. 2021. PMID: 33359613
-
Real-world application of the Xpert® HBV viral load assay on serum and dried blood spots.J Med Virol. 2021 Jun;93(6):3707-3713. doi: 10.1002/jmv.26662. Epub 2020 Nov 22. J Med Virol. 2021. PMID: 33174623
-
Test All for Hepatitis B Virus: Link to Care and Treatment if Quantitative DNA Positive, Vaccinate if Susceptible.Clin Liver Dis. 2023 Nov;27(4):997-1022. doi: 10.1016/j.cld.2023.05.009. Epub 2023 Jul 7. Clin Liver Dis. 2023. PMID: 37778782 Review.
-
Monitoring hepatitis B by using point-of-care testing: biomarkers, current technologies, and perspectives.Expert Rev Mol Diagn. 2021 Feb;21(2):195-211. doi: 10.1080/14737159.2021.1876565. Epub 2021 Feb 8. Expert Rev Mol Diagn. 2021. PMID: 33467927 Review.
Cited by
-
Multicenter Evaluation of the Cepheid Xpert® HBV Viral Load Test.Diagnostics (Basel). 2021 Feb 12;11(2):297. doi: 10.3390/diagnostics11020297. Diagnostics (Basel). 2021. PMID: 33673365 Free PMC article.
-
Point-of-Care Testing for Hepatitis Viruses: A Growing Need.Life (Basel). 2023 Nov 28;13(12):2271. doi: 10.3390/life13122271. Life (Basel). 2023. PMID: 38137872 Free PMC article. Review.
-
CRISPR/Cas13a-assisted rapid and portable HBV DNA detection for low-level viremia patients.Emerg Microbes Infect. 2023 Dec;12(1):e2177088. doi: 10.1080/22221751.2023.2177088. Emerg Microbes Infect. 2023. PMID: 36735916 Free PMC article.
-
How Could POCT be a Useful Tool for Migrant and Refugee Health?EJIFCC. 2021 Jun 29;32(2):200-208. eCollection 2021 Jun. EJIFCC. 2021. PMID: 34421489 Free PMC article. Review.
-
HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programme.JHEP Rep. 2022 Jul 9;4(10):100533. doi: 10.1016/j.jhepr.2022.100533. eCollection 2022 Oct. JHEP Rep. 2022. PMID: 36052221 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical